𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immunohistochemical detection of neuroendocrine differentiation in non-small-cell lung cancer and its clinical implications

✍ Scribed by Yoshihiko Segawa; Saburo Takata; Masanori Fujii; Isao Oze; Yoshiro Fujiwara; Yuka Kato; Atsuko Ogino; Eisaku Komori; Shigeki Sawada; Motohiro Yamashita; Rieko Nishimura; Norihiro Teramoto; Shigemitsu Takashima

Publisher
Springer-Verlag
Year
2009
Tongue
English
Weight
435 KB
Volume
135
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

RASSF1A gene inactivation in non-small c
RASSF1A gene inactivation in non-small cell lung cancer and its clinical implication
✍ Hideki Endoh; Yasushi Yatabe; Shigeki Shimizu; Kohei Tajima; Hiroyuki Kuwano; Ta πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 227 KB πŸ‘ 1 views

## Abstract Methylation‐associated inactivation of __RASSF1__, a putative tumor suppressor identified at 3p21.3, is reported in several cancers. We examined __RASSF1__ in non‐small lung cancer (NSCLC) to search for clinical implications. RT‐PCR analysis showed no expression of __RASSF1A__ in 12 of

Genomewide loss of heterozygosity and it
Genomewide loss of heterozygosity and its clinical associations in non small cell lung cancer
✍ Ruo-Chia Tseng; Jer-Wei Chang; Feng-Jen Hsien; Ya-Hui Chang; Chin-Fu Hsiao; Jung πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 462 KB πŸ‘ 1 views

## Abstract We extensively allelotyped a panel of 71 microdissected primary surgically resected non small cell lung cancer (NSCLC) tumors to identify chromosomal regions that are likely to contain tumor suppressor genes (TSGs) or associated with clinicopathologic and prognostic effects. Loss of het